Reuters logo
BRIEF-Rigel Pharmaceuticals enters into amendment to controlled equity offerings sales agreement
May 30, 2017 / 8:51 PM / 4 months ago

BRIEF-Rigel Pharmaceuticals enters into amendment to controlled equity offerings sales agreement

May 30 (Reuters) - Rigel Pharmaceuticals Inc

* Entered into amendment no. 1 to controlled equity offerings sales agreement, dated august 18, 2015 - SEC filing

* Co may offer and sell through Cantor additional shares of co’s common stock, having aggregate offering price of up to $40.0 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below